Former billionaire investor Sung Kook “Bill” Hwang has been sentenced to 18 years in prison for his role in the collapse of Archegos Capital Management, which led to losses of over $10 billion for Wall Street banks. Hwang was convicted of 10 criminal charges, including wire and securities fraud, and market manipulation. The collapse of…
billion on The Soothsayer / page 6
Comcast, the US media giant, has announced plans to spin off its cable television networks, including USA, Oxygen, and E!, as the company shifts its focus towards streaming services. This move comes as millions of viewers continue to cut the cord and rely on platforms like Netflix, YouTube, and Amazon Prime Video for their entertainment…
Anthropic, a leading AI startup, has secured an additional $4 billion from Amazon, solidifying their partnership and cementing Amazon’s position as a minority investor. The deal requires Anthropic to train its flagship generative AI models primarily on Amazon Web Services (AWS), Amazon’s cloud computing division. This strategic move is expected to accelerate the development of…
Large cryptocurrency investors are shifting their attention from XRP and ADA to a new meme coin called DOGEN, which is poised for explosive growth. Predictions suggest that DOGEN could soar by 10,000% in the coming months, catching the eye of the entire crypto community. The DOGEN lifestyle promises a life of luxury and success, with…
The biotech industry is witnessing a surge in the development of bispecific antibodies, a type of targeted therapy that can deliver two-in-one treatments to patients with cancer and other diseases. Several companies, including Adaptin Bio, Akeso, AP Biosciences, Candid Therapeutics, Summit Therapeutics, and Zenas BioPharma, are working on various bispecific antibody candidates, some of which…
The biotech industry is witnessing a surge in the development of exosome therapy companies, which are harnessing the potential of these tiny vesicles to treat a range of diseases, including cancer, neurological disorders, and inflammatory diseases. With several companies advancing their candidates through clinical trials, the global exosome therapeutics market is expected to grow significantly…
The meme coin revolution is in full swing, with tokens like Dogecoin, Shiba Inu, and Floki Inu gaining massive popularity. BTFD Coin, a new player in the market, is poised to dominate with its unique Play-to-Earn game and high-yield staking rewards. As the meme coin bull run continues, investors are looking for the next big…
The biotech industry is witnessing a surge in the development of GPCR (G protein-coupled receptor) therapies, with eight promising biotechs acquiring funding to fortify their pipelines. These biotechs are working on various GPCR-targeted drugs to address numerous diseases, including neuropathic pain, cancer, and metabolic disorders. The market for GPCR drugs is expected to grow significantly,…
Multiple sclerosis is a chronic disease of the central nervous system that affects nearly one million people in the U.S. alone. Biotech companies are working to expand therapeutic options for the disease, which is currently treated with disease-modifying drugs. Several companies, including Biogen, Immunic Therapeutics, Kyverna Therapeutics, Progentos Therapeutics, TG Therapeutics, and Zenas BioPharma, are…
Lunex Network, a newcomer in the altcoin market, is expected to experience a massive 18x rally by the end of its presale, with analysts predicting up to 1800% gains for LNEX holders. Meanwhile, Shiba Inu and Pepe investors are taking notice, with Shiba Inu’s price surging by 49.63% over the last seven days and Pepe…
